Blockade of Tumor-Expressed PD-1 promotes lung cancer growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of Tumor-Expressed PD-1 promotes lung cancer growth

Published:2018-01-29 Issue:4 Volume:7 Page:e1408747
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Du Shisuo¹,McCall Neal¹,Park Kyewon¹,Guan Qing²,Fontina Paolo³,Ertel Adam³,Zhan Tingting⁴,Dicker Adam P.¹,Lu Bo¹

Affiliation:

1. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA

2. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

3. Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA

4. Department of Pharmacology and Experimental Therapeutics, Division of Biostatistics, Thomas Jefferson University, Philadelphia, PA, USA

Funder

NCI

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1408747

Reference38 articles.

1. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies

2. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

3. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

4. Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

5. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors;Clinical and Translational Oncology;2024-09-03

2. Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade;Nature Communications;2024-08-26

3. Expression of programmed cell death protein 1 and programmed cell death ligand 1 in feline injection site fibrosarcomas;Research in Veterinary Science;2024-08

4. Expression of Immune Checkpoint Regulator Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death Protein Ligand 1 (PD-L1) in Invasive Ductal Carcinoma Breast;Indian Journal of Surgical Oncology;2024-06-13

5. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression;Molecular Therapy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3